Re: Reporting recommendations for tumor marker prognostic studies (REMARK) (multiple letters) [3]

Journal of the National Cancer Institute

Volumn 97, Issue 24, 2005, Pages 1855-1856

  Popat, Sanjay ^a   Houlston, Richard S ^b   McShane, Lisa M ^c   Altman, Douglas G ^d   Sauerbrei, Willi ^e   Taube, Sheila ^c   Gion, Massimo ^f   Clark, Gary M ^g  

^a MAIDSTONE HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF FREIBURG   (Germany)

^f Ospedale Civile   (Italy)

^g OSI PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ACCESS TO INFORMATION; ACCURACY; BIOINFORMATICS; CANCER RESEARCH; CANCER SURVIVAL; CONFIDENCE INTERVAL; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; PUBLISHING;

BIOMEDICAL RESEARCH; HUMANS; META-ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESEARCH DESIGN; TUMOR MARKERS, BIOLOGICAL;

EID: 29844441890     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji445     Document Type: Letter

References (0)